Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835133 · ClinicalTrials.gov registry record
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
A clinical trial of Familial Pancreatic Cancer, sponsored by Mayo Clinic.
- Active
- Registry status
- 1,122
- Enrollment target
- 1
- Study location
NCT00835133: Active study of Familial Pancreatic Cancer, sponsored by Mayo Clinic.
NCT00835133 is a study of Familial Pancreatic Cancer that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 1,122 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00835133, a study of Familial Pancreatic Cancer, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,122 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER medical chart review
- OTHER survey administration
Study Locations (1)
Minnesota
- Mayo Clinic Cancer Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,122 participants |
| Start Date | 2002-08-01 |
| Est. Completion | 2027-09-30 |
What the registry record for NCT00835133 still lists
NCT00835133 is an observational study that tracks outcomes without assigning an intervention. Its 1,122 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Familial Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which biologic sample preservation procedure is the first listed.
NCT00835133 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00835133 about?
NCT00835133 is a clinical study titled "Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma". RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease...
What is the current status of trial NCT00835133?
This trial is currently active not recruiting. The enrollment target is 1,122 participants. The study started on 2002-08-01. Estimated completion is 2027-09-30.
What conditions does trial NCT00835133 study?
This clinical trial studies the following conditions: Familial Pancreatic Cancer.
What interventions are being tested in trial NCT00835133?
The interventions under investigation include: biologic sample preservation procedure (OTHER), medical chart review (OTHER), survey administration (OTHER).
Who is sponsoring clinical trial NCT00835133?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835133 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- NCT06952504 · 1,123 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI